Impax Laboratories, Inc. has several generic drugs waiting to be approved and many branded medications. The company wants to expand its Hayward presence to benefit its research and development operations.
IMPAX has contracted with Webcor Construction Inc. of San Francisco to build a pharmaceutical dosage form manufacturing facility in its recently leased 50,000-square-foot building in Hayward. It is anticipated that this facility will be operational in mid-2002.
Impax recently bought a 50,400-square-foot building at 31153 San Antonio Street in Hayward to Impax Laboratories Inc. for $4.9 million.Impax plans to construct a $15.9 million manufacturing plant near its current Hayward location at 30831 Huntwood Avenue., which houses about 80 employees. With the new facility, the company expects to have 325 employees by 2005.
Dan Bergen and Ian Stuart of Colliers International represented Webcor Builders, the seller of the Hayward building. John Steinbuch of Colliers represented Impax.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
